Application no. and date | 11791161.0 (espacenet) (Federated) (European Patent Register), 20111118 | Patent/reg. no. and date | DK/EP 2640362, 20140910 | Publication date | 20130925 | Priority no. and date | US 415600 P, 20101119 | EP pub. no. and date |
EP 2640362 20130925 | Effective date | | Applicant/owner | Gilead Sciences, Inc., 333 Lakeside Drive
Foster City, CA 94404, US, Janssen Sciences Ireland UC, Eastgate Village, Eastgate
Little Island, County Cork, IE | Applicant ref. no. | V161118DK | Inventor | OLIYAI, Reza, 1504 Alturas Drive
Burlingame California 94010, US, WISER, Lauren, 10093 Senate Way
Cupertino California 95014, US, MENNING, Mark, 9 Hugo Street
San Francisco California 94122, US | Representative | Marks & Clerk LLP, 44 rue de la Vallée
BP 1775
L-1017 Luxembourg, LU | Opponent | | IPC Class | A61K 31/505 (2006.01) , A61K 31/513 (2006.01) , A61K 31/675 (2006.01) , A61K 9/20 (2006.01) , A61P 31/18 (2006.01) | Title | TERAPEUTISKE SAMMENSÆTNINGER, DER OMFATTER RILPIVIRIN HCL OG TENOVOFIR-DISOPROXILFUMARATE | Int. application no. | US2011061515 | Int. publication no. | WO2012068535 | Related patent (certificate) | | Status | Ændret DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|